Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
884.48
-1.46 (-0.16%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Novo Nordisk Shares Decline Amid Competitive Pressure
July 25, 2024
Novo Nordisk A/S Common Stock (NYSE: NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).
Via
Benzinga
3 Top-Performing Stocks Beating the Big Names in 2024
July 25, 2024
The following top-performing stocks may continue to gain as the Magnificent Seven runs out of steam in July.
Via
InvestorPlace
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
July 25, 2024
Viking Therapeutics Inc (NASDAQ:VKTX) shares are rising Thursday after the biotech company announced plans to advance its experimental weight loss drug to late-stage trials.
Via
Benzinga
Why Eli Lilly and Company Shares Are Moving Lower On Thursday
July 25, 2024
Eli Lilly and Company stock is trading lower on Thursday after Viking Therapeutics announced the advancement of its novel treatment for obesity, VK2735.
Via
Benzinga
3 Companies Gearing Up for a Stock Split
July 25, 2024
These stock split candidates could follow the route of Nvidia, Walmart and Chipotle Mexican Green in the near future.
Via
InvestorPlace
Expert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
July 24, 2024
Via
Benzinga
Market Whales and Their Recent Bets on LLY Options
July 23, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
July 25, 2024
Via
Benzinga
Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk
July 25, 2024
Viking Therapeutics stock rocketed Thursday after the company said it's exploring a monthly dose of its weight-loss drug.
Via
Investor's Business Daily
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:AXSM) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks
July 25, 2024
It takes a special set of circumstances for high-growth stocks to double in value in one year but analyst says these three can do it.
Via
InvestorPlace
Elon Musk Agrees With Former Executive Who Thinks 'Everyone' Has 'Strong' Opinions On Tesla Unlike In The Case Of Eli Lilly And LVMH
July 25, 2024
Investors have strong opinions on Tesla but not on LVMH or Eli Lilly, Musk agrees on Twitter. Tesla's controversial CEO and recent financial struggles may explain heightened interest.
Via
Benzinga
3 Fabulous Growth Stocks to Buy and Hold Forever
July 24, 2024
The bull market in growth stocks is more than just chipmakers if investors will only widen their lens to see the opportunities available.
Via
InvestorPlace
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
Wegovy, a GLP-1 receptor agonist, had previously been approved for use in obesity treatment and weight management.
Via
Benzinga
3 Dividend Growth Stocks That Have Doubled Their Payouts in 5 Years
July 24, 2024
Their yields may seem low, but these stocks have been growing their dividend payments at a fast pace.
Via
The Motley Fool
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
July 24, 2024
Could today's momentum continue?
Via
The Motley Fool
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.
Via
The Motley Fool
Don’t Delay! 3 Stocks to Buy BEFORE Q2 Earnings.
July 22, 2024
These stocks to buy before earnings are likely to jump higher after the companies behind them report their Q2 financial results.
Via
InvestorPlace
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
July 22, 2024
President Biden's decision to drop out may harm healthcare and create market volatility. Kamala Harris could defend his record and support Medicare for All.
Via
Benzinga
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
July 22, 2024
HC Wainwright initiated coverage on AnaptysBio with a Buy rating and a $55 price target. AnaptysBio focuses on immunology therapeutics with a promising pipeline.
Via
Benzinga
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
July 22, 2024
Pharmaceutical giants like Roche, Eli Lilly, Novo Nordisk, and Pfizer are racing to develop oral weight loss medications. These drugs promise to complement existing injectables, offering new hope in...
Via
Benzinga
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.
July 22, 2024
Eli Lilly is still a smart pick, but these two stocks could grow more in the near term.
Via
The Motley Fool
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
July 21, 2024
The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.
Via
The Motley Fool
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?
July 20, 2024
At least one of the pair has a credible shot at finding a home in the market.
Via
The Motley Fool
SPDR ETF Report For Friday, July 19
July 20, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Friday, July 19.
Via
Talk Markets
Topics
ETFs
Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications
July 19, 2024
Skyrocketing demand for GLP-1 medications for weight loss is causing shortages, impacting type 2 diabetics. While some insurers are limiting off-label use, government agencies have yet to prioritize...
Via
Benzinga
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
July 19, 2024
Eli Lilly's Tirzepatide approved by China's NMPA for long-term weight management, targeting adults with specific BMI criteria.
Via
Benzinga
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
This biotech stock fits the profile of a potentially big winner to a T.
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.